| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2424052A1 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | CA2421893A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | CA2421106A1 Manzamines for treatment of drug resistant infection |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420944A1 Inhibition of cmv infection and dissemination |
| 03/07/2002 | CA2420879A1 Anti-microbial agents |
| 03/07/2002 | CA2420871A1 Cephalosporin antibiotics and prodrugs thereof |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2420286A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | CA2420122A1 7-oxo pyridopyrimidines |
| 03/07/2002 | CA2420103A1 Modulation of fas and fasl expression |
| 03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
| 03/07/2002 | CA2419616A1 Novel ester or amide derivatives |
| 03/07/2002 | CA2419561A1 Method for treating the central nervous system by administration of igf structural analogs |
| 03/07/2002 | CA2419399A1 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | CA2419342A1 G-protein coupled receptors |
| 03/07/2002 | CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
| 03/07/2002 | CA2419251A1 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1184388A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof |
| 03/06/2002 | EP1183383A1 Siv-based packaging-deficient vectors |
| 03/06/2002 | EP1183382A2 Method for selecting improved vectors |
| 03/06/2002 | EP1183376A1 Isoflavonoid methylation enzyme |
| 03/06/2002 | EP1183371A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal |
| 03/06/2002 | EP1183368A2 Proteinfragmente die verschiedene epitope der hpv proteine e6 und e7 umfassen, ihre herstellung und verwendungen insbesondere zur impfung |
| 03/06/2002 | EP1183359A2 Nucleic acids and proteins with interferon-beta activity |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183344A2 Adam polynucleotides and polypeptides |
| 03/06/2002 | EP1183333A1 Methods of using rnase p reaction mechanisms of action |
| 03/06/2002 | EP1183332A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 03/06/2002 | EP1183274A1 Method and compounds for inhibiting activity of serine elastases |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183258A1 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 03/06/2002 | EP1183256A1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 03/06/2002 | EP1183242A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183047A2 Pharmaceutical preparation |
| 03/06/2002 | EP1183037A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 03/06/2002 | EP1183034A1 Modulators of methylation for control of bacterial virulence |
| 03/06/2002 | EP1183031A1 Quinoxaline containing medicaments for post exposure prophylaxis of an hiv infection |
| 03/06/2002 | EP1183026A2 Improved pharmaceutical formulations |
| 03/06/2002 | EP1183014A1 Controlled release and taste masking oral pharmaceutical compositions |
| 03/06/2002 | EP1183013A2 Melt granulation |
| 03/06/2002 | EP1182927A1 Antimicrobial sanitizing lotion with skin protection properties |
| 03/06/2002 | EP0756595B1 Substituted 1,3-oxathiolanes with antiviral properties |
| 03/06/2002 | EP0703784B1 Release and mobilisation of haematopoietic cells |
| 03/06/2002 | CN2479952Y Nm silver plaster for trauma |
| 03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 03/06/2002 | CN1339064A Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 03/06/2002 | CN1338947A Novel mucosal delivery system |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338925A Enteric coated pharmaceutical tablet and method of manufacturing |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338310A Epitope vaccine of hog cholera virus and its preparing process |
| 03/06/2002 | CN1338309A Synthetic peptide vaccine of hog cholera and its preparing process |
| 03/06/2002 | CN1338308A Synthetic peptide vaccine of influenzand its preparing process |
| 03/06/2002 | CN1338287A Medicine for treating pulmonary tuberculosis and its preparing process |
| 03/06/2002 | CN1338269A Medicine for treating cold and its preparing process |
| 03/06/2002 | CN1338258A Antibacterial clindamycin phosphate powder injection and its preparing process |
| 03/06/2002 | CN1338257A Cream for treating dermatopathy |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080300C Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 03/06/2002 | CN1080299C Vaccinal efficacy augmentor and efficacy augmenting foods |
| 03/06/2002 | CN1080264C Oxathiolanes, method for their preparation and pharmaceutical compoistions containing same |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/06/2002 | CN1080116C Use of medicinal feed for systemic treatment of fish diseases |
| 03/05/2002 | US6353093 gidB |
| 03/05/2002 | US6353055 Polycation homopolymer or copolymer |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6352991 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352984 For treatment of psychological disorders, schizophrenia |
| 03/05/2002 | US6352983 Antibiotics and bactericides |
| 03/05/2002 | US6352978 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | US6352717 Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
| 03/05/2002 | US6352702 Antimicrobial composition |
| 03/05/2002 | US6352696 Viral capsomeres; vaccines; gene expression, genetic engineering |
| 03/05/2002 | CA2145290C Methods and compositions for controlling translation of hcv proteins |
| 03/05/2002 | CA2079463C Live vaccines |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002016608A1 New sequences |
| 02/28/2002 | WO2002016554A1 Probiotics products containing lactic acid bacterium |
| 02/28/2002 | WO2002016440A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | WO2002016437A2 Rhabdovirus-based vectors to express high levels of functional human antibodies |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016382A1 Improved specificity in treatment of diseases |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |